NSTM Stock Overview
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
NovelStem International Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.07 |
52 Week High | US$0.28 |
52 Week Low | US$0.06 |
Beta | 0.13 |
1 Month Change | 6.06% |
3 Month Change | 11.29% |
1 Year Change | -65.00% |
3 Year Change | -75.00% |
5 Year Change | -22.22% |
Change since IPO | -99.18% |
Recent News & Updates
Recent updates
Shareholder Returns
NSTM | US Biotechs | US Market | |
---|---|---|---|
7D | 14.8% | -0.06% | 2.1% |
1Y | -65.0% | 9.8% | 30.4% |
Return vs Industry: NSTM underperformed the US Biotechs industry which returned 9.8% over the past year.
Return vs Market: NSTM underperformed the US Market which returned 30.4% over the past year.
Price Volatility
NSTM volatility | |
---|---|
NSTM Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 11.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NSTM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NSTM's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | n/a | n/a | https://www.novelstem.com |
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.
NovelStem International Corp. Fundamentals Summary
NSTM fundamental statistics | |
---|---|
Market cap | US$3.28m |
Earnings (TTM) | -US$1.29m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.5x
P/E RatioIs NSTM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NSTM income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$1.29m |
Earnings | -US$1.29m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.028 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 9.7% |
How did NSTM perform over the long term?
See historical performance and comparison